Stocks Health care NIVF
NASDAQ · Health careNewGenIvf Group Ltd (NIVF)
NewGenIvf Group Ltd reported revenue of $23.7M in fiscal 2025, up 336.3% from a year earlier. Net income was $9.9M, a net margin of 41.7%. In fiscal 2025 capital spending exceeded operating cash flow by $11.1M. At December 31, 2025 it held $758.6K in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 31, 2026.
What NewGenIvf Group Ltd does
NewGenIvf Group Ltd is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NASDAQ under the ticker NIVF.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $23.7M | $9.9M | $3.04 | -$11.1M |
| 2024 | $5.4M | -$524.6K | -$4,408.76 | -$8.3M |
| 2023 | $5.1M | $130.2K | $13,019.30 | -$1.8M |
| 2023 | $5.9M | $458.7K | $17,408.24 | $1.6M |
| 2021 | $4.1M | -$533 | $0.00 | $1.4M |
Full financial statements: income, balance sheet and cash flow
Where NIVF ranks in Health care
Latest SEC filings
What NewGenIvf Group Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 10, 2026
- September 1, 2026
- August 20, 2026
- August 18, 2026
- August 17, 2026
- July 31, 2026
- July 30, 2026
- July 27, 2026
- July 6, 2026
- July 1, 2026
Insider trades
What the people running NewGenIvf Group Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $2.5M worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 27, 2026 | Cheung Kong YiuDirector, 10% owner | Bought | 2,500,000 | $2.5M |
| June 18, 2026 | Cheung Kong YiuDirector, 10% owner | Bought | 500,000 | $665K |
| June 2, 2026 | Cheung Kong YiuDirector, 10% owner | Bought | 500,000 | $665K |
| May 28, 2026 | Cheung Kong YiuDirector, 10% owner | Bought | 222,223 | $333.3K |
Who owns NIVF
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
1 insiders reported holding 3,722,223 shares in total, about $2.1M at the last price.
| Holder | Shares |
|---|---|
| Cheung Kong YiuDirector, 10% owner | 3,722,223 |
Questions about NIVF
What does NewGenIvf Group Ltd do?
NewGenIvf Group Ltd is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NASDAQ under the ticker NIVF.
Is NewGenIvf Group Ltd profitable?
Yes. In fiscal 2025 it reported net income of $9.9M on revenue of $23.7M, a net margin of 41.7%.
How much revenue does NewGenIvf Group Ltd make?
In fiscal 2025 NewGenIvf Group Ltd reported revenue of $23.7M. That is 336.3% more than a year earlier.
When did NewGenIvf Group Ltd last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 31, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the iPO registration (foreign issuer) (amended) from September 10, 2026.
Similar companies
Compare NIVF with
Follow NIVF
Get an email when NewGenIvf Group Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Follow NIVF: get an email when it filesWhere the numbers come from
Financial figures are the values NewGenIvf Group Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.